Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Thursday following insider selling activity. $207.87 million flowed into the stock on the tick-up and $290.47 million flowed out of the stock on the tick-down, for a money net flow of $82.60 million out of the stock. Of all equities tracked, UnitedHealth Group had the 14th highest net out-flow for the day. UnitedHealth Group traded up $1.02 for the day and closed at $253.27Specifically, Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the sale, the director now directly owns 182,372 shares in the company, valued at approximately $44,682,963.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 17th. The shares were sold at an average price of $260.55, for a total value of $3,908,250.00. Following the completion of the sale, the director now owns 193,872 shares in the company, valued at $50,513,349.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,000 shares of company stock worth $6,466,350. 0.87% of the stock is owned by insiders.
Several analysts recently commented on UNH shares. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 21st. Cantor Fitzgerald restated a “buy” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research report on Wednesday, November 21st. BMO Capital Markets set a $310.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research report on Tuesday, November 27th. Piper Jaffray Companies raised their target price on UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a research report on Wednesday, November 28th. Finally, Oppenheimer raised their target price on UnitedHealth Group from $295.00 to $300.00 and gave the company an “outperform” rating in a research report on Wednesday, November 28th. Two investment analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $297.80.
The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64. The company has a market cap of $235.93 billion, a PE ratio of 19.66, a price-to-earnings-growth ratio of 1.26 and a beta of 0.79.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th will be paid a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s payout ratio is currently 27.95%.
Hedge funds and other institutional investors have recently modified their holdings of the business. Crewe Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $25,000. Pearl River Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $35,000. Ipswich Investment Management Co. Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $40,000. OLD Second National Bank of Aurora boosted its stake in shares of UnitedHealth Group by 70.0% during the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock worth $42,000 after acquiring an additional 70 shares in the last quarter. Finally, Laurel Wealth Advisors LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $42,000. 85.80% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Traders Sell UnitedHealth Group (UNH) on Strength Following Insider Selling” was originally published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/4221832/traders-sell-unitedhealth-group-unh-on-strength-following-insider-selling.html.
About UnitedHealth Group (NYSE:UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Cost of equity and a company’s balance sheet
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.